Ticagrelor Ab

Ticagrelor Ab is an antiplatelet medication used to reduce the risk of blood clots in patients with heart conditions. It belongs to the class of P2Y12 inhibitors and is taken orally. This product is manufactured by Aurobindo N.V. and is available in the EU.

Ticagrelor Ab is primarily used to prevent blood clots in people with acute coronary syndrome or a history of heart attack. It works by blocking platelets from sticking together, reducing the risk of further cardiovascular events. This medication is often prescribed alongside low-dose aspirin for enhanced effectiveness. It is also used to reduce the risk of stroke in patients with certain heart conditions.

Ticagrelor Ab helps maintain healthy blood flow by preventing platelets from clumping together. Users may notice improved circulation and reduced chest pain or shortness of breath associated with heart conditions. Some individuals report feeling more energetic as their cardiovascular health stabilizes. Regular use supports long-term heart health and reduces the likelihood of clot-related complications.

Store Ticagrelor Ab in a cool, dry place away from direct sunlight. Keep it out of reach of children and pets. If you experience unusual bleeding or bruising, seek medical attention immediately. Avoid crushing or splitting the tablets unless advised by a healthcare professional. Always follow the storage instructions provided with the medication.

Ticagrelor Ab may interact with other blood thinners, such as warfarin or nonsteroidal anti-inflammatory drugs (NSAIDs). Combining it with certain antibiotics or antifungals can also affect its effectiveness. Grapefruit juice may increase the risk of side effects, so it is advisable to limit consumption. Always inform your healthcare provider about all medications and supplements you are taking.